Stay informed with the latest updates for the inheritable blood disorders community.

NHF 70th: Saluting HTC Nurses
NHF 70th: Saluting HTC Nurses
Medical
NHLBI Workshop on Factor VIII Inhibitors is Less Than Two Weeks Away!
NHLBI Workshop on Factor VIII Inhibitors is Less Than Two Weeks Away!
Medical
Patient Education Leads to Drop in Prosthetic Joint Infections
Patient Education Leads to Drop in Prosthetic Joint Infections
Peer-Reviewed Journal Summaries
Study Suggests Prophylaxis Could Reduce Hospitalizations for VWD Patients
Study Suggests Prophylaxis Could Reduce Hospitalizations for VWD Patients…
NBDF & Community
HANDI Highlights: Healthy Living Resources to the Community
HANDI Highlights: Healthy Living Resources to the Community
Medical
NHF Announces Telegenetics Investigation
NHF Announces Telegenetics Investigation
Medical
VONVENDI® Receives Expanded FDA Approval for Surgery in VWD Patients
VONVENDI® Receives Expanded FDA Approval for Surgery in VWD Patients
Medical
Two New MASAC Documents Issued
MASAC Safety Information Update on Emicizumab (HEMLIBRA)
Medical
Two New MASAC Documents Issued
MASAC Issues New Treatment Recommendation
Envisioning “Treatment for All” on World Hemophilia Day
Envisioning “Treatment for All” on World Hemophilia Day
Industry
Genentech Patient Foundation Responds to NHF-HFA Letter
HEMLIBRA® Receives Breakthrough Designation from FDA
Industry
ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
Industry
Genentech Provides Updates on Hemlibra Product Particles
Grifols Announces 2017 Factor Product Donations to WFH Humanitarian…
NHF CEO Shares Vision with Chapters
NHF CEO Shares Vision with Chapters
NHF 70th: The Fight to Preserve ACA Patient Protections Goes On
NHF 70th: The Fight to Preserve ACA Patient Protections Goes On